Keyphrases
Peripheral Neuropathy
100%
AIDS Clinical Trials
100%
Vicriviroc
100%
Placebo
50%
Treatment Experience
37%
HIV Infection
25%
Human Immunodeficiency Virus Type 1 (HIV-1)
12%
Randomized Placebo-controlled Trial
12%
Current Therapies
12%
Generalized Estimating Equations
12%
Antiretroviral Therapy
12%
Nucleoside Reverse Transcriptase Inhibitors
12%
Ritonavir
12%
HIV RNA
12%
Neuropathy
12%
Neurological Complications
12%
Ankle Reflex
12%
Baseline CD4
12%
Painful Neuropathy
12%
Hypoactive
12%
Medicine and Dentistry
Clinical Trial
100%
Neuropathy
100%
Vicriviroc
100%
Placebo
55%
Human Immunodeficiency Virus
33%
Human Immunodeficiency Virus Infection
22%
Antiretroviral Therapy
11%
Physical Disease by Body Function
11%
Neurological Complication
11%
Ritonavir
11%
Reverse-Transcriptase Inhibitor
11%
Achilles Reflex
11%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Neuropathy
100%
Vicriviroc
100%
Placebo
55%
HIV
33%
Human Immunodeficiency Virus Infection
22%
Physical Disease by Body Function
11%
Ritonavir
11%
RNA Directed DNA Polymerase Inhibitor
11%
Neurological Complication
11%
Immunology and Microbiology
Human Immunodeficiency Virus 1
100%
Human Immunodeficiency Virus Infection
100%
CD4
50%
Human Immunodeficiency Virus
50%
Reverse Transcriptase
50%
Achilles Reflex
50%
Neuroscience
Vicriviroc
100%
Neuropathy
100%
Placebo
55%
Human Immunodeficiency Virus
55%
CD4
11%
Reverse-Transcriptase Inhibitor
11%
Achilles Reflex
11%
Ritonavir
11%